NeuroSense Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). 

CEO
Alon Ben-Noon
CEOAlon Ben-Noon
Employees
16
Employees16
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
16
Employees16

NRSN Key Statistics

Market cap
4.50M
Market cap4.50M
Price-Earnings ratio
-0.20
Price-Earnings ratio-0.20
Dividend yield
—
Dividend yield—
Average volume
29.78K
Average volume29.78K
High today
$2.60
High today$2.60
Low today
$2.28
Low today$2.28
Open price
$2.29
Open price$2.29
Volume
22.24K
Volume22.24K
52 Week high
$25.40
52 Week high$25.40
52 Week low
$2.15
52 Week low$2.15

Stock Snapshot

As of today, NeuroSense Therapeutics(NRSN) shares are valued at $2.35. The company's market cap stands at 4.5M, with a P/E ratio of -0.20.

On 2026-10-27, NeuroSense Therapeutics(NRSN) stock moved within a range of $2.28 to $2.60. With shares now at $2.35, the stock is trading +3.1% above its intraday low and -9.6% below the session's peak.

Trading volume for NeuroSense Therapeutics(NRSN) stock has reached 22.24K, versus its average volume of 29.78K.

Over the past 52 weeks, NeuroSense Therapeutics(NRSN) stock has traded between a high of $25.40 and a low of $2.15.

Over the past 52 weeks, NeuroSense Therapeutics(NRSN) stock has traded between a high of $25.40 and a low of $2.15.

NRSN News

TipRanks 1d
NeuroSense Therapeutics Moves to Early PrimeC Commercialization in U.S.

Neurosense Therapeutics Ltd. ( (NRSN) ) has provided an update. On October 26, 2026, NeuroSense Therapeutics announced it has signed a strategic collaboration...

People also own

Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.